Eramol

About Eramol

Eramol is a UK and EU-based pharmaceutical services company providing end-to-end sterile and non-sterile manufacturing and clinical supply solutions. Founded, owned and led by Qualified Persons, Eramol places quality, regulatory compliance and product protection at the core of every programme. Services span manufacturing, aseptic fill-finish, packaging and labelling, QC testing, UK/EU QP release, regulatory support, storage and global distribution, supporting clients from early clinical development through to commercial supply.

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    United Kingdom
  • On CPHI since:
    2026
  • Certificates:
    4
  • Employees:
    25 - 49
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
  • +447783700174
  • Website
  • Unit 9 North Downs Business Park, Limepit Lane,, TN13 2TL, Sevenoakes, United Kingdom
Show contact info Hide contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

Products from Eramol (5)

  • Non Sterile Manufacturing

    Product Non Sterile Manufacturing

    Oral dosage forms (tablets, capsules, oral liquids)Actives and placebos
  • Packaging & Labelling

    Product Packaging & Labelling

    Primary and Secondary packaging and labelling capabilities 
  • QP Release

    Product QP Release

    QP Release into UK & EU market
  • Sterile Fill Finish

    Product Sterile Fill Finish

    Aseptic and Terminal sterilisationsmall moleculelarge molecule/biologicsADCsATMPSCell & Gene TherapyPeptidesOligonucleotidesRadiopharmaViral Vectors
  • Storage & Distribution

    Product Storage & Distribution

    Storage and global distribution capabilities 

Eramol Resources (1)

  • New Sterile Manufacturing Facility (End to End CMO service)

    News New Sterile Manufacturing Facility (End to End CMO service)

    Eramol’s new sterile manufacturing facility at its Sevenoaks campus is a purpose-built, EU GMP Annex 1 aligned site designed to support early-phase sterile injectable programmes. The facility features isolator-based aseptic fill-finish and terminal sterilisation, with phase-appropriate batch sizes and a strong focus on sterility assurance and product protection, achieving <1% line losses. Fully integrated with Eramol’s wider services, the facility provides an end-to-end sterile solution including packaging and labelling, QC testing, UK/EU QP release, regulatory support, GMP/GDP storage and global distribution, with planned expansion to support later-stage and commercial manufacturing.
    22 Jan 2026